Krystal Biotech to Present at 5th Annual Evercore ISI HealthCONx Conference

Rhea-AI Summary

Krystal Biotech, Inc. (NASDAQ: KRYS) announced its participation in the Evercore ISI 5th Annual HealthCONx Conference, scheduled from November 29 to December 1, 2022. CEO Krish S. Krishnan will engage in a fireside chat and conduct investor meetings on November 30. A webcast of the presentation will be available at 10:30 am ET on November 30, and further details can be found on the Company’s investor website.

Krystal focuses on developing genetic medicines for rare diseases, leveraging its proprietary redosable HSV vector technology.

PITTSBURGH, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases, announced today that the Company will participate in the Evercore ISI 5^th Annual HealthCONx Conference, which is taking place virtually from November 29-December 1.

Krish S. Krishnan, Chairman and Chief Executive Officer, will participate in a fireside chat during the conference and host investor meetings on November 30.

A webcast of the presentation will be available here at 10:30 am ET on Wednesday, November 30 and will be posted on the Investor section of the Company’s website.

About Krystal Biotech, Inc.

Krystal Biotech, Inc. (NASDAQ: KRYS) is a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases. The Company’s wide-ranging pipeline is based on its proprietary redosable HSV vector. Headquartered in Pittsburgh, Pennsylvania, the Company is led by an experienced management team, is fully-integrated and has core capabilities in viral vector design, vector optimization, gene therapy manufacturing and commercialization. For more information, please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and Twitter.

CONTACT:

Investors and Media                                                                
Meg Dodge                                                      
Krystal Biotech                                                    
mdodge@krystalbio.com                                             
Source: Krystal Biotech, Inc.

 

FAQ

What is the date of the Evercore ISI HealthCONx Conference for KRYS?

The Evercore ISI HealthCONx Conference is taking place virtually from November 29 to December 1, 2022.

Who from Krystal Biotech will speak at the conference?

CEO Krish S. Krishnan will participate in a fireside chat during the conference and host investor meetings on November 30.

When will the presentation webcast for KRYS be available?

The webcast of the presentation will be available at 10:30 am ET on November 30, 2022.

What is the focus of Krystal Biotech, Inc.?

Krystal Biotech focuses on developing and commercializing genetic medicines for patients with rare diseases.

What technological platform does Krystal Biotech utilize?

Krystal Biotech utilizes its proprietary redosable HSV vector technology in its genetic medicine development.